VIable
HLCCompendium
HLCCompendium
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
NDHI<br />
NAT IONAL DIALOGUE FOR<br />
Healthcare Innovation<br />
must pass quality assurance review and is categorized<br />
with a severity rating to determine overall costs saved:<br />
• Level 1 - Adherence Support<br />
• Level 2 - Reduced Medication Cost<br />
• Level 3 - Prevented a Physician Visit<br />
• Level 4 - Prevented an Additional Prescription Order<br />
• Level 5 - Prevented an Emergency Room Visit<br />
• Level 6 - Prevented Hospital Admission<br />
• Level 7 - Prevented Life-threatening Situation<br />
Value Delivered<br />
The value of the program is in the avoidance, mitigation,<br />
and resolution of medication related issues, including<br />
gaps in care, non-adherence, dosing inconsistencies,<br />
adverse drug reactions / interactions, and duplications<br />
of care:<br />
• Program return-on-investment has consistently<br />
exceeded $3:$1 and has reached as high as $10:$1<br />
• A recent analysis of the OutcomesMTM adherence<br />
interventions for a Medicaid plan showed improvement<br />
in adherence to medications treating diabetes,<br />
hypertension and cholesterol:<br />
––<br />
Overall, the proportion of adherent members<br />
at the end of 2015 was 12% higher in the<br />
Successful Intervention group than the No<br />
Intervention group<br />
• 83% of surveyed patients who received a Comprehensive<br />
Medication Review (CMR) from their<br />
participating pharmacies rated the CMR at a 4/5<br />
or a 5/5<br />
Path Forward<br />
Currently, OutcomesMTM is:<br />
• Working with pharmacy providers to increase the<br />
number of members served and the number of<br />
successfully completed MTM services<br />
• Developing other channels to ensure patients are<br />
able to receive MTM services, such as a telephonic<br />
pharmacy team, long term care facilities and health<br />
system pharmacists<br />
• Creating a medication reconciliation service to help<br />
address hospital readmissions<br />
In the longer term, the company will continue to:<br />
• Collaborate with associations and other organizations<br />
to share results and findings from the company’s<br />
programs<br />
• Focus its programs on the goal of changing patient<br />
and prescriber behaviors around medication use.<br />
In a quality-focused health care marketplace, those<br />
programs that best lead to behavior change will be<br />
the most successful<br />
OutcomesMTM<br />
| 62